RecruitingPhase 2 / Phase 3NCT07646678
Rare condition
Idiopathic hypersomnia
18
studies recruiting now
as of 7 Sept 2026
55
studies registered in total
as of 7 Sept 2026
10
countries with a recruiting site
as of 7 Sept 2026
15 Jun 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT06252571
a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial
RecruitingPhase 3NCT07625280
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
RecruitingPhase 3NCT07500090
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
RecruitingPhase 2 / Phase 3NCT06767683
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 18 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Idiopathic hypersomnia study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Idiopathic hypersomnia
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
8 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Pitolisant (Wakix)
Phase 2/3Sodium Oxybate (Lumryz)
Phase 2Pentylenetetrazol (Cardiazol)
Phase 2Serdexmethylphenidate
Phase 2Solriamfetol
Phase 2Clarithromycin (Biaxin)
Phase 1/2Flumazenil (Anexate)
Phase 1Danavorexton
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).